Gamma-Secretase Inhibitors Attenuate Neurotrauma and Neurogenic Acute Lung Injury in Rats by Rescuing the Accumulation of Hypertrophic Microglia

Background/Aims: In response to traumatic brain injury (TBI), activated microglia exhibit changes in their morphology from the resting ramified phenotype toward the activated hypertrophic or amoeboid phenotype. Here, we provide the first description of the mechanism underlying the neuroprotective effects of γ-secretase inhibitors on TBI outcomes in rats. Methods: The neuroprotective effects of γ-secretase inhibitors such as LY411575 or CHF5074 on TBI-induced neurotoxicity were analysed using a neurological motor function evaluation, cerebral contusion assay, immunohistochemical staining for microglia phenotypes, lung injury score and Evans Blue dye extravasation assay of brain and lung oedema. Results: Hypertrophic or amoeboid microglia accumulated in the injured cortex, the blood-brain-barrier was disrupted and neurological deficits and acute lung injury were observed 4 days after TBI in adult rats. However, a subcutaneous injection of LY411575 (5 mg/kg) or CHF5074 (30 mg/kg) immediately after TBI and once daily for 3 consecutive days post-TBI significantly attenutaed the accumulation of hypertrophic microglia in the injured brain, neurological injury, and neurogenic acute lung injury. Conclusion: Gamma-secretase inhibitors attenuated neurotrauma and neurogenic acute lung injury in rats by reducing the accumulation of hypertrophic microglia in the vicinity of the lesion.

• Publication year

  2017

• Venue

  Cellular Physiology and Biochemistry

• Publication date

  2017-12-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000485778PMID 29227981
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute brain trauma, lung injury, and pneumonia: more than just altered mental status and decreased airway protection.

  2017cited by this paper
• Translational Research in Acute Lung Injury and Pulmonary Fibrosis Early coagulation events induce acute lung injury in a rat model of blunt traumatic brain injury

  2016cited by this paper
• Evaluation of TgH(CX3CR1-EGFP) mice implanted with mCherry-GL261 cells as an in vivo model for morphometrical analysis of glioma-microglia interaction

  2016cited by this paper
• Perivascular microglia promote blood vessel disintegration in the ischemic penumbra

  2015cited by this paper
• The Ischemic Environment Drives Microglia and Macrophage Function

  2015cited by this paper
• Morphometric characterization of microglial phenotypes in human cerebral cortex

  2014cited by this paper
• Therapeutic Efficacy of Neuro AiD™ (MLC 601), a Traditional Chinese Medicine, in Experimental Traumatic Brain Injury

  2014cited by this paper
• 2‐Methoxyestradiol confers neuroprotection and inhibits a maladaptive HIF‐1α response after traumatic brain injury in mice

  2014cited by this paper
• Astragaloside improves outcomes of traumatic brain injury in rats by reducing microglia activation.

  2014cited by this paper
• The HMGB1-RAGE axis mediates traumatic brain injury–induced pulmonary dysfunction in lung transplantation

  2014cited by this paper
• Etanercept Attenuates Traumatic Brain Injury in Rats by Reducing Brain TNF-α Contents and by Stimulating Newly Formed Neurogenesis

  2013cited by this paper
• CHF5074 restores visual memory ability and pre‐synaptic cortical acetylcholine release in pre‐plaque Tg2576 mice

  2013cited by this paper
• P4–294: Gamma‐secretase as a target for Alzheimer's disease therapy: Small‐molecule development

  2013cited by this paper
• Etanercept attenuates traumatic brain injury in rats by reducing early microglial expression of tumor necrosis factor-α

  2013cited by this paper
• Review: Activation patterns of microglia and their identification in the human brain

  2013cited by this paper
• Towards clinical management of traumatic brain injury: a review of models and mechanisms from a biomechanical perspective

  2013cited by this paper
• CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo-Controlled Study.

  2013cited by this paper
• Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice

  2013cited by this paper
• CHF5074 reduces biomarkers of neuroinflammation in patients with mild cognitive impairment: a 12-week, double-blind, placebo-controlled study.

  2013cited by this paper
• Plasma glutamate–modulated interaction of A2AR and mGluR5 on BMDCs aggravates traumatic brain injury–induced acute lung injury

  2013cited by this paper
• Traumatic Brain Injury, Microglia, and Beta Amyloid

  2012cited by this paper
• Microglial activation induced by brain trauma is suppressed by post-injury treatment with a PARP inhibitor

  2012cited by this paper
• Trauma Hemorrhagic Shock-Induced Lung Injury Involves a Gut-Lymph-Induced TLR4 Pathway in Mice

  2011cited by this paper
• Resolution of acute lung injury and inflammation: a translational mouse model

  2011cited by this paper
• γ-secretase inhibitors and modulators for the treatment of Alzheimer's disease: disappointments and hopes.

  2011cited by this paper
• An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals.

  2011cited by this paper
• Contribution of Neutrophils to Acute Lung Injury

  2011cited by this paper
• Capillary blood flow around microglial somata determines dynamics of microglial processes in ischemic conditions

  2011cited by this paper
• Mild Fluid Percussion Injury in Mice Produces Evolving Selective Axonal Pathology and Cognitive Deficits Relevant to Human Brain Injury

  2010cited by this paper
• CHF5074, a Novel γ-Secretase Modulator, Restores Hippocampal Neurogenesis Potential and Reverses Contextual Memory Deficit in a Transgenic Mouse Model of Alzheimer's Disease

  2010cited by this paper
• Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia-reperfusion injury.

  2010cited by this paper
• T Cell Pathways Involving CTLA4 Contribute To a Model of Acute Lung Injury

  2010cited by this paper
• Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer's disease

  2009cited by this paper
• CHF5074, a novel γ‐secretase modulator, attenuates brain β‐amyloid pathology and learning deficit in a mouse model of Alzheimer's disease

  2009cited by this paper
• Adenosine A2A receptor mediates microglial process retraction

  2009cited by this paper
• SIMVASTATIN ATTENUATES MICROGLIAL CELLS AND ASTROCYTE ACTIVATION AND DECREASES INTERLEUKIN‐1B LEVEL AFTER TRAUMATIC BRAIN INJURY

  2009cited by this paper
• An inclined plane system with microcontroller to determine limb motor function of laboratory animals.

  2008cited by this paper
• Brain Trauma Leads to Enhanced Lung Inflammation and Injury: Evidence for Role of P4504Fs in Resolution

  2007cited by this paper
• Microglia: active sensor and versatile effector cells in the normal and pathologic brain

  2007cited by this paper
• Therapeutic Anti-Inflammatory Effects of Myeloid Cell Adenosine Receptor A2a Stimulation in Lipopolysaccharide-Induced Lung Injury1

  2007cited by this paper
• High tidal volume is associated with the development of acute lung injury after severe brain injury: An international observational study*

  2007cited by this paper
• Adenosine A2A receptor activation reduces lung injury in trauma/hemorrhagic shock*

  2006cited by this paper
• ATP mediates rapid microglial response to local brain injury in vivo

  2005cited by this paper
• Oxygenation Inhibits the Physiological Tissue-Protecting Mechanism and Thereby Exacerbates Acute Inflammatory Lung Injury

  2005cited by this paper
• Chronic Treatment with the γ-Secretase Inhibitor LY-411,575 Inhibits β-Amyloid Peptide Production and Alters Lymphopoiesis and Intestinal Cell Differentiation*

  2004cited by this paper
• Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation.

  2004cited by this paper
• The development of acute lung injury is associated with worse neurologic outcome in patients with severe traumatic brain injury.

  2003cited by this paper
• Neutrophils and acute lung injury

  2003cited by this paper
• Secretase as a target for Alzheimer's disease.

  2002cited by this paper
• Microglial chemotaxis, activation, and phagocytosis of amyloid β-peptide as linked phenomena in Alzheimer's disease

  2001cited by this paper
• Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in Rats

  2001cited by this paper
• Decreased perihematomal edema in thrombolysis-related intracerebral hemorrhage compared with spontaneous intracerebral hemorrhage.

  2000cited by this paper
• Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema.

  2000cited by this paper
• Transcranial cytokine gradients in patients requiring intensive care after acute brain injury.

  1997cited by this paper
• Alterations in Regional Cerebral Blood Flow following Brain Injury in the Rat

  1991cited by this paper
• Traumatic Brain Injury in the Rat: Characterization of a Midline Fluid-Percussion Model

  1987cited by this paper
• Cellular Neuroscience Perspective Article Microglia in Action: How Aging and Injury Can Change the Brain's Guardians

  year unknowncited by this paper

• Selective Gamma-Secretase Inhibition by CHF5074 Attenuates Inflammation and Neovascularization in a Murine Model of Choroidal Neovascularization

  2025cites this paper
• Validation of a simplified model for subarachnoid hemorrhage in mice

  2024influential citation
• Neuroprotection and Beyond: The Central Role of CB1 and CB2 Receptors in Stroke Recovery

  2023cites this paper
• A high throughput blood-brain barrier model incorporating shear stress with improved predictive power for drug discovery.

  2023cites this paper
• Increasing Severity of Spinal Cord Injury Results in Microglia/Macrophages With Annular-Shaped Morphology and No Change in Expression of CD40 and Tumor Growth Factor-β During the Chronic Post-injury Stage

  2022cites this paper
• Polydatin alleviates severe traumatic brain injury induced acute lung injury by inhibiting S100B mediated NETs formation.

  2021cites this paper
• Effects of CNS Injury-Induced Immunosuppression on Pulmonary Immunity

  2021cites this paper
• Mesenchymal stem cells activate Notch signaling to induce regulatory dendritic cells in LPS-induced acute lung injury

  2020cites this paper
• Remote Ischemic Conditioning Reduced Acute Lung Injury After Traumatic Brain Injury in The Mouse.

  2020cites this paper
• Differences in pathological changes between two rat models of severe traumatic brain injury

  2019cites this paper
• Leucine-rich repeat kinase-2 (LRRK2) modulates paraquat-induced inflammatory sickness and stress phenotype

  2019cites this paper
• Exercise Preconditioning Attenuates Neurological Injury by Preserving Old and Newly Formed HSP72-Containing Neurons in Focal Brain Ischemia Rats

  2019cites this paper
• MiR-135a Protects Vascular Endothelial Cells Against Ventilator-Induced Lung Injury by Inhibiting PHLPP2 to Activate PI3K/Akt Pathway

  2018cites this paper
• HSP-70-Mediated Hyperbaric Oxygen Reduces Brain and Pulmonary Edema and Cognitive Deficits in Rats in a Simulated High-Altitude Exposure

  2018cites this paper